Characterization of the mutation responsible for aspartylglucosaminuria in three Finnish patients. Amino acid substitution Cys163—-Ser abolishes the activity of lysosomal glycosylasparaginase and its conversion into subunits
Open accessThe DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
The mutation that causes a deficiency of the lysosomal amidase, glycosylasparaginase, has been characterized in fibroblasts from three Finnish patients diagnosed with aspartylglucosaminuria (AGU). The polymerase chain reaction was used to amplify the glycosylasparaginase protein coding sequence from the three AGU patients in order to compare them to the normal sequence from a full-length human placenta cDNA clone HPAsn.6 (Fisher, K.J., Tollersrud, O.K., and Aronson, N.N., Jr. (1990) FEBS Lett. 269, 440-444). Two base changes were found to be common to all three Finnish AGU patients, a G482----A transition that results in an Arg161----Gln substitution and a G488----C transversion that causes Cys163----Ser. Detection of both point mutations from PCR-amplified cDNA or genomic DNA was facilitated by their creation of new endonuclease restriction sites. Expression studies in COS-1 cells revealed only the Cys163----Ser mutation caused a deficiency of glycosylasparaginase activity. This same substitution also prevented the normal posttranslational processing of the precursor glycosylasparaginase polypeptide into its alpha and beta subunits. Cell-free expression of the single-chain glycosylasparaginase precusor did not produce an active enzyme, suggesting that post-translational generation of subunits may be required for catalytic activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NA02057, from a female with aspartylglucosaminuria (OMIM #208400), characterized as a compound heterozygote, was homozygous for two adjacent substitutions (AGA exon 4, c.482G>A, R161Q, chr4:178596918G>A and exon 4, c.488G>C, C163S, chr4:178596912G>C in 38 of 39 reads; Fig. 8), of which C163S had been shown to be the disease mutation (43).”
From Carrier testing for severe childhood recessive diseases by next-generation sequencing (2011) · cites this paper as [43]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Molecular Cloning. A Laboratory Manual
Wood, E. (1983) · Biochemical Education · doi:10.1016/0307-4412(83)90068-7 · Cited by 29,533
PCR protocols — A guide to methods and applications
U.G. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90252-7 · Cited by 11,702
Antibodies: A laboratory manual
J.L. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90307-1 · Cited by 5,089
A MODIFIED COLORIMETRIC METHOD FOR THE ESTIMATION OF N-ACETYLAMINO SUGARS
Reissig, J. L., Strominger, J. L., & Leloir, L. F. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65959-9 · Cited by 2,585
The CpG dinucleotide and human genetic disease
Cooper, D. N., & Youssoufian, H. (1988) · Human Genetics · doi:10.1007/bf00278187 · Cited by 931
[71] Use of eukaryotic expression technology in the functional analysis of cloned genes
Cullen, B. R. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)52074-2 · Cited by 822
ALTERNATIVE SPLICING IN THE CONTROL OF GENE EXPRESSION
Smith, C. W. J., Patton, J. G., & Nadal-Ginard, B. (1989) · Annual Review of Genetics · doi:10.1146/annurev.ge.23.120189.002523 · Cited by 692
Deletion in Cysteine-Rich Region of LDL Receptor Impedes Transport to Cell Surface in WHHL Rabbit
Yamamoto, T., Bishop, R. W., Brown, M. S., Goldstein, J. L., & Russell, D. W. (1986) · Science · doi:10.1126/science.3010466 · Cited by 335
Research works printed but not linked: 3
- Jenner, 1967, Biochem. J, 103, 48P
- Aula, 1986, J. Ment. Defic. Res, 30, 365
- Kincaid, 1988, BioTechniques, 6, 42
Cited by
Carrier testing for severe childhood recessive diseases by next-generation sequencing
Bell, C. J., Dinwiddie, D. L., Miller, N. A., Hateley, S. L., Ganusova, E. E., Mudge, J., Langley, R. J., Zhang, L., Lee, C. C., Schilkey, F. D., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001756 · Cited by 706
“8), of which C163S had been shown to be the disease mutation (43).”
BackgroundActivation of Glycosylasparaginase
Guan, C., Cui, T., Rao, V., Liao, W., Benner, J., Lin, C.-L., & Comb, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1732 · Cited by 180
Gieselmann, V. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(94)00075-2 · Cited by 158
Bonten, E. J., Campos, Y., Zaitsev, V., Nourse, A., Waddell, B., Lewis, W., Taylor, G., & d'Azzo, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.031419 · Cited by 87
Ikonen, E., Julkunen, I., Tollersrud, O. K., Kalkkinen, N., & Peltonen, L. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05656.x · Cited by 67
Metadata
- Authors
- Fisher, K. J., & Aronson, N. N.
- Affiliations
- Pennsylvania State University (US)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1991-06
- Volume
- 266
- Issue
- 18
- Pages
- 12105-12113
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1502576134
- Cited by
- 52
- References
- 37
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 2 · 2021: 2 · 2020: 3 · 2017: 1 · 2016: 2 · 2014: 3
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 10741 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk033314-12)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK33314)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Keywords
- aspartylglucosaminuria, glycosylasparaginase, point mutations, post-translational processing, enzyme activity loss, Finnish patients, fibroblasts, restriction site mutations
- MeSH terms
- Acetylglucosamine, Amino Acid Sequence, Aspartylglucosylaminase, Base Sequence, Cysteine, DNA, Fibroblasts, Finland, Humans, Lysosomes, Molecular Sequence Data, Mutation, RNA, Messenger, Serine, Protein Biosynthesis, Blotting, Southern, Blotting, Northern, Restriction Mapping, Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of the mutation responsible for aspartylglucosaminuria in three Finnish patients. Amino acid substitution Cys163—-Ser abolishes the activity of lysosomal glycosylasparaginase and its conversion into subunits. https://app.cochat.ai/papers/10.1016/s0021-9258(18)99071-x
- The paper
- Fisher, K. J., & Aronson, N. N. (1991). Characterization of the mutation responsible for aspartylglucosaminuria in three Finnish patients. Amino acid substitution Cys163—-Ser abolishes the activity of lysosomal glycosylasparaginase and its conversion into subunits. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(18)99071-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.